Author Information
Gelin Xu is a prominent figure in the field of neurology, currently affiliated with the Department of Neurology at Jinling Hospital, which is part of the Southern Medical University in Nanjing, Jiangsu, China. He also holds an affiliation with the Medical School of Nanjing University, indicating his active involvement in both clinical and academic neurology. His contributions to the field, particularly in stroke research, are recognized internationally, making him a key contributor to advancements in neurological science.Research Contributions
Gelin Xu has made significant contributions to the understanding and treatment of ischemic stroke, as evidenced by his numerous publications in this area. His research spans a variety of topics including the implications of sympathetic hyperactivity after cerebral infarction, the impact of COVID-19 on stroke treatment, and innovative approaches to predicting stroke outcomes. Notable studies include exploring the relationship between malnutrition and mortality in ischemic stroke patients, and the prediction of stroke recurrence using nomograms. His work has been crucial in advancing treatment protocols and improving patient outcomes in the realm of stroke management.Aliases
Gelin Xu is also known by the aliases Ge-li Xu and Gelin Xu, which are used interchangeably in various publications and academic references. These aliases ensure that all his research contributions are accurately attributed to him across different platforms and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
44,667 |
| H-Index |
55 |
| Total Paper Count |
285 |
